The integration of PCR (the polymerase chain reaction method used to amplify and detect specific sequences of DNA) into The State’s consumption safety requirements for cannabis has caused a steep increase in test failure for the cultivation community. The detection of disease-causing Aspergillus has become a devastating source of cannabis crop loss, significantly impacting growers’ sellable cannabis products. The validation and state approval now allows
“Aspergillus is one of the most common industry-wide causes of cannabis product testing failure. Since PCR has become the required method for routine micro testing, one of the major challenges has been the potential detection of DNA from dead Aspergillus cells,” stated
“This ultimately delivers a more accurate depiction of any live Aspergillus DNA present in any given sample of cannabis or hemp. Free DNA Removal prior to PCR can also provide the cultivator with an important tool to determine the efficacy of any mitigation practices for Aspergillus contamination,” Heather added.
About
Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's inability to consummate the closing of the Steep Hill acquisition, need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the
Corporate Contact:
702-527-2060
Investor Relations & Financial Media
Integrity Media
team@integritymedia.com
Toll Free: (888) 216-3595
www.IntegrityMedia.com
Source:
2022 GlobeNewswire, Inc., source